Dennis Serrette serves as Senior Vice President & Chief Partnership(s) Officer at the National Urban League (NUL). Mr. Serrette brings more than 30 years of success in board and fund development, business development, strategic planning, and sales management.
During his tenure, the NUL completed the most successful single fundraising campaign in the history of African American lead institutions raising $278 million. Prior to joining the League, Mr. Serrette served as Vice President, Corporate Development at United Way of New York City where he was responsible for overall management and growth of their $65 million annual campaign and played a pivotal role in the fundraising administration and donor relations for the September 11th Fund.
Mr. Serrette attended Pace University for undergraduate studies and has recently completed his MBA, Finance at Stetson University.
Senior Vice President & Chief Partnership(s) Officer, National Urban League (NUL)
A well-known business leader in global and U.S. pharmaceutical pricing, reimbursement, and market access, Dr. Robert DeFrantz is recognized for his expertise in global health systems, including all U.S. payer segments, major European payer systems, and Japan.
Dr. DeFrantz formulates successful business strategies, proactively conducts competitive assessments, identifies capabilities for organizational improvement, and demonstrates cross-functional leadership, all of which lead to groundbreaking wins for patients and companies.
Following a 20-year career at Eli Lilly and Company, where he served as Senior Director, Oncology, Global Pricing, Reimbursement, & Market Access, in 2017, Dr. DeFrantz joined AbbVie as Senior Director, Immunology, Global Market Access, & Pricing.
Dr. DeFrantz earned his PharmD from Xavier University College of Pharmacy and his undergraduate degree from Indiana University–Purdue University Indianapolis.
Head of US Value & Access, Oncology, Sanofi Genzyme
Dr. Craig Cole is a board-certified hematologist and serves as the Director of Clinical Research in Hematology/ Oncology and Multiple Myeloma at the Michigan State University College of Human Medicine at Breslin Cancer Center. Dr. Cole has been the on-site primary investigator for over 30 clinical trials and participated in over 50 clinical trials in Multiple Myeloma and Malignant Hematology. He has been published in national journals and presented his research at the American Society of Hematology and the American Society for Apheresis national meetings. Indicative of his commitment to equity of cancer care, patient empowerment, and community education, Dr. Cole has won awards for his work in teaching, Multiple Myeloma research, and patient advocacy.
Dr. Cole received his Bachelor of Science degree in physiology at Michigan State University and the College of Lyman Briggs, East Lansing Michigan, and earned a doctoral degree at the Ohio State University College of Medicine in Columbus, Ohio.
Director of Clinical Research in Hematology/Oncology, Breslin Cancer Center
